Cargando…
Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC
BACKGROUND: We aimed to investigate the β-klotho (KLB) expression in non-small cell lung cancer (NSCLC) and to determine its value as a novel molecular target for survival prognosis in patients with NSCLC. METHODS: The serum KLB concentrations in 50 patients with NSCLC and the 20 healthy persons wer...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182533/ https://www.ncbi.nlm.nih.gov/pubmed/34164204 http://dx.doi.org/10.21037/jtd-21-798 |